
Simulations Plus Investor Relations Material
Latest events

Q2 2025
Simulations Plus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Simulations Plus Inc
Access all reports
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. Through an extensive network of consultants, SPI provides insight in addition to the science of molecular modeling services and expert testimony in litigation relating to molecular property analysis, from both a scientific and business perspective. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
Key slides for Simulations Plus Inc


Q1 2025
Simulations Plus Inc


Q2 2025
Simulations Plus Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SLP
Country
🇺🇸 United States